Oncology Clinical Trial Finder
Breast Cancer

Active, not recruiting • Phase NA • Stage 0, I, II, III, IV • Post-Menopausal • Non-interventional

The following is imported from ClinicalTrials.gov:

Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)

The purpose of this study is to use a magnetic resonance imaging (MRI) sequence called golden-angle radial compressed sensing and parallel imaging (GRASP) as a noninvasive and fast way to measure the wash-in contrast (dye) in the breast. MRI uses a strong magnetic field and radio waves to create images of structures in the body. The goal is to determine if benign and malignant breast lesions have different patterns of contrast wash in. This study will ask woman planning to undergo a clinical breast MRI with contrast (dye) as part of their standard care.

Breast Cancer

Study Design
Study type:


Estimated enrollment:

264 participant

Actual study start date:

July 31, 2018

Eligibility Criteria
Ages eligible for study:

0 - 999

Sexes eligible for study:


Arms and Intervention
  • Predictive Model

  • Breast Imagers

Inclusion criteria
  • no contraindications to mri scanning (pacemaker, implanted metallic objects, severe obesity or other condition that leads to difficulty lying in the magnet)

  • able and willing to provide informed consent

Exclusion criteria
  • currently undergoing neoadjuvant chemotherapy for breast cancer treatment.

Trial Information at Site
Last Updated:
Trial Information
ClinicalTrial.gov ID:

Active, not recruiting

Estimated Enrollment:


Last Updated:


Principal Investigator

Laura Heacock, MD

Trial Sponsor

NYU Langone Health

Study Location (1)

NYU Langone Health

New York, New York, United States


© 2024 Outcomes4Me Inc. All rights reserved.